Reduce costs and improve outcomes associated with Asthma and COPD
Increase inhaler adherence and improve technique.
90% Of patients with Asthma & COPD take their inhaler incorrectly resulting in <20% of medication reaching a user’s lungs. This has a negative impact on patient outcomes and increases the costs associated with managing these conditions.
Supplying the BreatheSuite MDI Device to patients is an effective and efficient way to remotely provide individualized care that will increase inhaler adherence and technique, while decreasing the overall economic burden associated with these conditions.
North American Yearly Expenditures (Asthma + COPD)*
- Tools enable a patient to learn proper inhaler technique and adherence through personalized, real-time inhaler feedback
- Healthcare professionals can monitor patients' technique remotely, in real-time
- Data analysis - trend one patient or the entire clinic to help determine the cause of exacerbations
- Utilize existing RPM codes
Request a Demo
Learn how your organization and clients can benefit from incorporating BreatheSuite into your practice
Thank you! Your submission has been received!
Oops! Something went wrong while submitting the form.
*AL-Jahdali et al. (2013). Improper inhaler technique is associated with poor asthma control and frequent emergency department visits. Retrieved from https://www.researchgate.net/publication/236063055_Improper_inhaler_technique_is_associated_with_poor_asthma_control_and_frequent_emergency_department_visits
Lewis, A. (2016). The economic burden of asthma and chronic obstructive pulmonary disease and the impact of poor inhalation technique..”. Retrieved from https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4942909/